GYMISO (misoprostol) - Termination of pregnancy

Opinions on drugs - Posted on Sep 09 2024

Reason for request

Reassessment

Summary of opinion

Favourable opinion for reimbursement in the:

“Medical termination of early pregnancy of less than 49 days of amenorrhea, in combination with mifepristone.
Preparation of the cervix for surgical termination of pregnancy in the first trimester.

Clinical Benefit

Substantial

The Committee deems that the clinical benefit of GYMISO 200 micrograms (misoprostol) is substantial.

Clinical Added Value

no clinical added value

Cette spécialité est un complément de gamme qui n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à la présentation déjà inscrite.